TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now? [Yahoo! Finance]
Doximity, Inc. Class A (DOCS)
Company Research
Source: Yahoo! Finance
Tempus is focused on advancing precision medicine through artificial intelligence. The company aggregates and structures multimodal data from clinical care and laboratory testing and provides AI-enabled solutions to physicians, researchers, payers and biopharmaceutical companies. Doximity is a medical network in the United States, reaching over 80% of U.S. physicians and 60% of advanced practice providers. The company's GPT and AI-powered tools are seeing strong adoption, with usage growing more than fivefold year over year and gaining traction among prescribers and health system partners. DOCS offers an attractive blend of profitability, scale, and digital defensibility, albeit with selective execution risks tied to client mix and macro visibility. With the global healthcare information systems market projected to surge to nearly $1,773.33 billion by 2034, per Precedence Research, investors are closely tracking opportunities in this space to enhance their portfolio. Here's a clos
Show less
Read more
Impact Snapshot
Event Time:
DOCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DOCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DOCS alerts
High impacting Doximity, Inc. Class A news events
Weekly update
A roundup of the hottest topics
DOCS
News
- Doximity (DOCS) had its price target lowered by Bank of America Corporation from $56.00 to $47.00. They now have a "buy" rating on the stock.MarketBeat
- Doximity (DOCS) Stock Dips While Market Gains: Key Facts [Yahoo! Finance]Yahoo! Finance
- Doximity (DOCS) had its price target lowered by KeyCorp from $38.00 to $30.00. They now have an "overweight" rating on the stock.MarketBeat
- Is Doximity (DOCS) One of the Stocks Set to Explode in the Next 3 Years? [Yahoo! Finance]Yahoo! Finance
- Doximity (DOCS) had its price target lowered by The Goldman Sachs Group, Inc. from $34.00 to $28.00. They now have a "neutral" rating on the stock.MarketBeat
DOCS
Earnings
- 2/5/26 - Beat
DOCS
Sec Filings
- 4/17/26 - Form 8-K
- 4/14/26 - Form 4
- 4/10/26 - Form 144
- DOCS's page on the SEC website